The 20 Best Pancreatic Ductal Adenocarcinoma Doctors Near Me in Sugar Land, TX

Mariam Babu is a Physician Assistant practicing medicine in Sugar Land, Texas. Ms. Babu is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma and Ampullary Cancer.

Danessa Coles is a Nurse Practitioner practicing medicine in Sugar Land, Texas. She has been practicing medicine for over 10 years. Ms. Coles is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Malabsorption, Vitamin B12 Deficiency, Febrile Neutropenia, and Pancreatic Ductal Adenocarcinoma. Ms. Coles is currently accepting new patients.

Moazzam Sana is a Gastroenterologist practicing medicine in Sugar Land, Texas. Dr. Sana is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Gas Bloat Syndrome, Familial Adenomatous Polyposis, Endoscopy, and Gastrostomy. Dr. Sana is currently accepting new patients.

Meng Chen is an Internal Medicine provider practicing medicine in Sugar Land, Texas. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Hives, Sinusitis, Angioedema, Allergic Rhinitis, and Splenectomy.

Sadia Saleem is a Hematologist practicing medicine in Sugar Land, Texas. Dr. Saleem is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Janet Tu is a Hematologist practicing medicine in Sugar Land, Texas. Dr. Tu is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 44 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).

Charles Conlon is a Hematologist practicing medicine in Sugar Land, Texas. Dr. Conlon is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, Non-Muscle Invasive Bladder Cancer, and Bone Marrow Aspiration.

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fisher is currently accepting new patients.

Dr. Tannaz Armaghany is Assistant Professor of Medicine-Hematology and Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Armaghany’s professional interests include: gastrointestinal medical oncology, neuroendocrine tumors, hepatocellular carcinoma, and hepatobiliary cancers.Dr. Armaghany received her medical degree from Tabriz University in Tabriz, Iran and completed her residency at Cook County Hospital in Chicago, Ill. She also completed fellowships in hematology and medical oncology at Louisiana State University Health in Shreveport, La. and integrative medicine at Arizona State University in Tucson, Ariz.Dr. Armaghany is board-certified in Medical Oncology, Hematology, and Internal Medicine from the American Board of Internal Medicine.Dr. Armaghany serves as President of the Texas branch of the Iranian American Medical Association. She is also a member of American College of Clinical Oncology, American Society of Hematology, North American Neuroendocrine Tumor Society, SWOG Cancer Research Network, Harris County Medical Society, International Society of Liver Cancer, and the Texas Medical Association. Dr. Armaghany is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Fibrolamellar Carcinoma, Gallbladder Cancer, and Gallbladder Adenocarcinoma. Dr. Armaghany is currently accepting new patients.

Nitesh Vachhani is a Gastroenterologist practicing medicine in Richmond, Texas. Dr. Vachhani is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 81 other conditions, according to our data. His clinical expertise encompasses Swallowing Difficulty, Painful Swallowing, Diverticular Disease, Gastrostomy, and Endoscopy.

Ebrahim Delpassand is a Nuclear Medicine provider practicing medicine in Houston, Texas. Dr. Delpassand is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Pancreatic Ductal Adenocarcinoma, Lacrimal Gland Tumor, and Liver Embolization.

Yang Yu is a Holistic Medicine provider practicing medicine in Katy, Texas. Mr. Yu is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Partial Deletion of Y, Bietti Crystalline Dystrophy (BCD), Trisomy 12 Mosaicism, Coronary Artery Bypass Graft (CABG), and Endoscopy.

Nirav Thosani is a Gastroenterologist practicing medicine in Bellaire, Texas. Dr. Thosani is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Choledocholithiasis, Bile Duct Obstruction, Pancreatic Cancer, Gastrostomy, and Endoscopy.

George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at Baylor College of Medicine. Dr. Van Buren is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gallbladder Cancer, Gallbladder Adenocarcinoma, Splenectomy, and Pancreatectomy. Dr. Van Buren is currently accepting new patients.

Dr. James Suliburk is a board-certified endocrine surgeon specializing in the treatment of tumors of the thyroid, parathyroid, and adrenal gland. He is an Associate Professor and Chief of Endocrine Surgery - Surgical Oncology at Baylor College of Medicine, where he is also Medical Director of Ambulatory Surgery Therapeutics (CfAST) in BCM’s Department of Surgery; and is a member of the Dan L Duncan Comprehensive Cancer Center.Dr. Suliburk’s clinical interests include: thyroid nodules; goiter; Graves’ disease; thyroid cancer; hyperparathyroidism; adrenal masses; pheochromocytoma; Cushing’s, Conn’s diseases; minimally invasive parathyroidectomy and thyroidectomy; traditional open thyroidectomy; central, selective and modified radical neck dissection; single incision laparoscopic adrenalectomy; and traditional laparoscopic adrenalectomy. His research interests include: clinical outcomes in endocrine surgery in underserved and minority populations; outcomes in acute care and trauma surgery; and the application of mobile technology to improve peri-operative surgical care and communication with patients to detect impending complications. His research program at Ben Taub Hospital and Baylor St. Luke’s Medical Center offers opportunities in translational science, clinical outcomes, and mobile technology development/innovation.Dr. Suliburk also collaborates with other colleagues within Baylor College of Medicine to actively seek and develop state of the art treatments for hemorrhagic shock and severely injured trauma patients. His translational research includes the development of novel molecular markers and therapeutic targets in endocrine surgical disease (thyroid cancer, hyperthyroidism, hyperparathyroidism, and adrenal tumors), and metabolic markers of the endocrine response in severely injured major trauma patients.Dr. Suliburk received his medical degree from the University of Oklahoma College of Medicine. He completed his residency in general surgery from The University of Texas Medical School at Houston and a fellowship in endocrine surgery from Royal North Shore Hospital, University of Sydney in Sydney, Australia. He also completed an NIH T32 research fellowship from The University of Texas Medical School at Houston.Dr. Suliburk is board-certified by the American Board of Surgery. He is a fellow of the American College of Surgeons and a member of the American Thyroid Association, American Association of Endocrine Surgeons, Houston Surgical Society, Association of Academic Surgeons, American Association for the Surgery of Trauma, Surgical Infection Society, and the ACS Academy of Master Surgeon Educators.Dr. Suliburk has been named a Top Doctor in General Surgery by Houstonia Magazine (2020). He has also received numerous awards in teaching excellence from Baylor College of Medicine. Dr. Suliburk is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Thyroid Nodule, Parathyroid Hyperplasia, Parathyroidectomy, and Thyroidectomy. Dr. Suliburk is currently accepting new patients.

Dr. Omar Barakat is a general surgeon specializing in benign and malignant diseases of the liver, bile duct, gallbladder, and pancreas. He is an Associate Professor of Surgery - Division of Surgical Oncology at Baylor College of Medicine and Medical Director of the Neuroendocrine Tumor Program at Baylor St. Luke’s Medical Center.Dr. Barakat’s clinical interests include: malignant hepatobiliary and pancreatic diseases, liver and pancreas surgery; upper gastrointestinal surgery; neuroendocrine tumors; gastrointestinal stromal tumors (GIST); and minimally invasive surgery.Dr. Barakat has developed new surgical techniques to minimize the complication rate and blood loss following pancreatic and liver surgeries. He utilizes image-guided therapies, such as radiofrequency ablation, microwave ablation, irreversible electroporation (NanoKnife system), trans-arterial chemotherapy, and selective internal radiotherapy (SIRT) with Yttrium-90 microspheres, to treat liver tumors while minimizing trauma to the patients. Dr. Barakat's clinical and research interests also include the study of neuroendocrine tumors; and the development of off-the-shelf bio-artificial liver organs that can be suitable for liver transplantation in patients with end-stage liver disease.Dr. Barakat received his medical degree from Aleppo University Medical School in Aleppo, Syria. He completed a residency in general surgery at the Medical College of Pennsylvania, Episcopal Hospital in Philadelphia and a Fellowship in cardiovascular surgery research at State University of New York - Buffalo. He also completed clinical fellowships in liver transplantation at The University of Texas Health Science Center in Houston; and in heart transplantation and mechanical assist devices aat the Texas Heart Institute. He continued his practice in liver and pancreatic surgery at Freeman Hospital in Newcastle Upon-Tyne, United Kingdom, where he treated complex and rare tumors of the liver, bile duct, and pancreas. Dr. Barakat is board-certified by the Royal College of Surgeons (Ed), United Kingdom, where he is also a Fellow. Dr. Barakat is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bile Duct Stricture, Chronic Pancreatitis, Gallbladder Disease, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Barakat is currently accepting new patients.

Curtis Wray is a General Surgeon practicing medicine in Bellaire, Texas. Dr. Wray is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Stomach Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Camille Canty is a Nurse Practitioner practicing medicine in Bellaire, Texas. Ms. Canty is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. Her clinical expertise encompasses Ampullary Cancer and Pancreatic Ductal Adenocarcinoma.

Madison Williams is an Oncologist practicing medicine in Houston, Texas. Dr. Williams is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Diffuse Large B-Cell Lymphoma (DLBCL), and B-Cell Lymphoma.

Mona Lisa is an Internal Medicine provider practicing medicine in Houston, Texas. Dr. Lisa is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.